WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES

Checking

 

EssilorLuxottica EL

ParisMedical instruments and suppliesFinancials to Sep 30, 2026 · Updated Nov 11, 2026

On Stock Analysis · affiliate link
EL financials
Moat score
83
ROIC
5.8%
P/E
34.5
EV/EBIT
26.0
FCF yield
4.5%
Dividend yield
1.9%
Market cap
€86.0B

Moat ranks

Score rankTied #100 of 396
Durabilitymedium
Market structureCompetitive
Pricing powermoderate

Balance sheet

6/30/26
€BDec 31Jun 30
Cash3.51.9
Securities0.00.0
Debt10.811.4
Net cash-7.3-9.5
Equity38.939.2
Leverage
Debt / EBITDA
1.67×
Debt / equity
0.29×
Leases (6/30/26)
€3.9B
Capital
Diluted shares
464M
Book value / share
€84.44
Price / book
2.2×
Net cash / share
−€20.41
Market cap
€86.0B
Enterprise value
€95.5B

Per-share record

Fiscal years and TTM
Scale
€0€20€40€60€80'16'17'18'19'20'21'22'23'2461.31'2563.06TTM
Revenue per shareCash flow per share

Key indicators

Latest: H1 '26
IndicatorLatestVs year agoLast 8 halves
Revenue growth5.7%+0.1 pts
Operating margin15.5%+1.2 pts
FCF margin10.3%-0.0 pts
Capex / revenue4.4%-0.8 pts
Comparable-store sales growth+7%–
Retail stores · 8/31/26~20,000–
Wholesale customers · 12/31/25≥300,000––
Professional Solutions revenue · 9/30/26€3.4B–
Royalty expense · 12/31/25€249M-1%

Margins and growth from reported quarters; company KPIs as reported in results releases.

About EL

EssilorLuxottica makes spectacle lenses, frames, sunglasses and smart glasses, and sells through professionals and its own retail network. FY2025 revenue was EUR28.491 billion, split 47.7% Professional Solutions and 52.3% Direct to Consumer.

Revenue mix
Direct to Consumer 52.3%Professional Solutions 47.7%
  • Distribution Control

    Scale and embedded relationships with eye care professionals, supported by integrated manufacturing and distribution, help reach and service a broad installed base of optical doors.

  • Brand Trust

    Iconic proprietary brands drive consumer preference and willingness-to-pay, supporting premium positioning across sunglasses and prescription eyewear.

  • Distribution Control

    Owned retail and direct e-commerce (brand sites and marketplaces) increase reach and data capture, and allow tighter control of merchandising and launches.

  • Contractual Exclusivity

    Licensing partnerships with leading fashion houses broaden premium assortment and can create quasi-exclusive access to brand IP for eyewear categories during contract terms.

Timeline
  1. Sep 9, 2026

    The board unanimously reaffirmed confidence in Francesco Milleri, Paul du Saillant and the group strategy after public criticism, preserving management continuity while highlighting governance tension.

  2. Aug 28, 2026

    EssilorLuxottica launched a program to buy up to 5 million shares, creating another use of cash; the release did not specify a cancellation.

  3. Aug 20, 2026

    A US randomized trial published in JAMA Ophthalmology reported that Stellest lenses slowed childhood myopia progression by 71% over two years, supporting the product's clinical differentiation.

  4. Apr 2, 2026

    EssilorLuxottica acquired a meaningful stake in Top Charoen, adding Thailand's nearly 2,000-store chain to its retail reach.

Financial record

Fiscal year2016201720182019202020212022202320242025TTMTrendChange 2016–25
Per share (€)
Revenue41.0341.6240.6939.4232.8744.4954.9656.3457.6261.3163.06+4.6%/yr
Cash flow5.927.268.867.486.7310.2010.7310.7810.6011.3911.38+7.5%/yr
Earnings3.844.714.072.440.193.254.835.085.134.985.37+2.9%/yr
Free cash flow2.954.266.195.435.257.897.217.397.298.108.27+11.9%/yr
Capex2.973.012.672.051.482.313.533.403.313.283.11+1.1%/yr
Dividends1.941.991.822.011.150.311.021.082.531.183.59-5.4%/yr
Book value26.1026.32123.5778.8873.5078.7184.0484.8387.7783.6984.44+13.8%/yr
Diluted shares (M)221221266441439445446451460465464+8.6%/yr
Totals (€B)
Revenue9.19.210.817.414.419.824.525.426.528.529.3+13.5%/yr
Operating income1.31.31.41.70.52.33.23.23.43.43.7+10.8%/yr
Net income0.91.01.11.10.11.42.22.32.42.32.5+11.8%/yr
Free cash flow0.70.91.62.42.33.53.23.33.43.83.8+21.5%/yr
Buybacks0.20.00.00.00.20.30.50.30.30.51.0+8.8%/yr
Dividends0.40.40.50.90.50.10.50.51.20.51.7+2.7%/yr
Net cash-1.1-0.7-1.9-2.4-1.3-6.7-7.1-5.9-7.3-7.3-9.5−€6.2B
Margins & returns (%)
Gross margin65.364.963.462.256.761.763.663.263.460.660.8-4.7 pts
Operating margin14.814.712.99.63.111.612.912.513.011.912.5-2.9 pts
Net margin9.411.310.06.20.67.38.89.08.98.18.5-1.2 pts
FCF margin7.210.215.213.816.017.713.113.112.613.213.1+6.0 pts
ROIC15.016.03.13.51.04.35.55.65.65.75.8-9.4 pts
Return on equity14.717.93.33.10.34.15.76.05.86.06.4-8.8 pts
R&D % of revenue–0.71.83.23.82.92.42.32.42.32.3–
Stock pay % of revenue0.10.00.81.01.21.10.80.90.81.21.0+1.1 pts
Capex % of revenue7.27.26.65.24.55.26.46.05.75.44.9-1.9 pts

Change uses 2016 and 2025 only: compound annual growth for amounts, points for margins and returns, and the change in amount for net cash. A dash means no 2016 base. Trend shows the fiscal years.

TTM = two half years to Sep 30, 2026. Per-share values use diluted weighted shares.ROIC = operating income × (1 − 22.7% tax rate, the company's own over three fiscal years excluding one-offs) ÷ (equity + debt − cash and current securities). Returns show a dash when their base is negative or under 10% of revenue. Free cash flow = operating cash flow − capex. Debt is all borrowings; net cash counts long-term securities and excludes leases.

Moat

Moat scorecard

Moat score83
Strength
Confidence
Structure
Competitive
Durability
medium
Trajectory
stable
Pricing power
moderate
Segments
  • Professional Solutions47.7%
    1 claim
  • Direct to Consumer52.3%
    3 claims

Moat claims

Applies to
Professional Solutions
Confidence
Durability
medium
Trajectory
stableas of Oct 7, 2026
Why it holds

Scale and embedded relationships with eye care professionals, supported by integrated manufacturing and distribution, help reach and service a broad installed base of optical doors.

Why stable

Professional Solutions revenue rose 7.8% at constant exchange rates in H1 2026, supporting channel reach, but no evidence shows that its more than 300,000 wholesale customers are exclusive.

Indicators
  • Wholesale customers≥300,000
  • Professional Solutions revenue€3.4B
Risks
  • Consolidation of optical chains increasing buyer power
  • DTC share gains reducing ECP channel influence
  • Regulatory/antitrust constraints on distribution practices

Profile change log

  1. Oct 7, 2026 · business change

    The board unanimously reaffirmed confidence in Francesco Milleri, Paul du Saillant and the group strategy after public criticism, preserving management continuity while highlighting governance tension.

  2. Oct 7, 2026 · business change

    EssilorLuxottica launched a program to buy up to 5 million shares, creating another use of cash; the release did not specify a cancellation.

  3. Oct 7, 2026 · business change

    A US randomized trial published in JAMA Ophthalmology reported that Stellest lenses slowed childhood myopia progression by 71% over two years, supporting the product's clinical differentiation.

  4. Oct 7, 2026 · business change

    EssilorLuxottica acquired a meaningful stake in Top Charoen, adding Thailand's nearly 2,000-store chain to its retail reach.

  5. Oct 7, 2026 · analyst revision

    Changed segment weights from H1 2026 to FY2025 reported revenue, added sourced moat trajectories, a bull and bear debate, management and two shared end-market profiles. Kept four claims and their strengths.

Industry & peers

Peer map

0%10%20%30%40%50%60708090100Moat scoreIndustry medianELALC

Hover a point for its values; click a peer to compare. Dashed lines: industry medians.

Global optical retail and eyewear

As of Oct 7, 2026
CompetitiveMedium cyclicality

Consumer sales of prescription spectacles, sunglasses and readers through optical stores and online channels, including eye examinations linked to spectacles. Contact lenses, eye surgery, apparel and hearing-care treatment are outside this profile.

  1. EssilorLuxottica
  2. VSP Vision
  3. Warby Parker
  4. Zenni Optical
2025 leaders, no comparable shares · Warby Parker FY2025 Form 10-K
StocksMoatGross m.Op. m.
EL8360.8%12.5%
Industry median108261.0%19.8%
Sector median557661.5%17.3%
All stocks median3987653.1%20.0%

Moat medians cover every stock. Margin medians count only stocks with collected numbers and need at least three.

Drivers & risks

Demand drivers
  • Aging, myopia and greater awareness of eye health support recurring demand for examinations and replacement glasses.
  • Insurance coverage and subscriptions can improve access and repeat visits; reimbursement rules vary by country.
  • Premium lenses, recognizable brands and AI glasses can raise spending per customer, but product mix changes retail margins.
  • Stores provide examinations, fitting and service, while online ordering gives consumers greater price transparency.
Risks
  • Fashion and premium sunglasses are more exposed to consumer confidence and travel spending than necessary vision correction.
  • Online sellers, independent opticians and other chains give consumers alternatives; a large store count does not by itself prove pricing power.
  • Store rent, wages and examination staffing raise fixed costs; weak traffic reduces store productivity.
  • Foreign exchange changes affect translated group results; tariffs and new wearable-product costs can offset sales growth.
  • Privacy, safety and product-liability rules can constrain AI-glasses adoption; brand demand also depends on the software partner.

Bulls & bears

Key question · as of Oct 7, 2026

Can AI glasses and premium vision care increase cash profit while preserving brand demand and productivity in the core optical network?

Arguments

3 forFaded: weakening or settled4 against

What to watch

  1. 1Comparable-store sales and wholesale constant-currency revenue
  2. 2Reported gross profit and wearables product mix
  3. 3Operating cash flow, capital expenditure and gross treasury purchases

Next check: FY2026 results: test optical and retail economics after Q3 revenue of EUR7,486m, retail comparable-store growth of 6.8%, and constant-currency myopia-management and wearables growth of 24% and 20%. Separate acquisition, currency and launch effects from retention.

Sources: company filings and dated sources collected for Find My Moat; market cap as of Nov 10, 2026. Not investment advice.

Cite or reuse this data

Free to reuse, commercially too, with a credit link. See the data license.

Moat Score 83/100 by <a href="https://www.findmymoat.com/stocks/XPAR:EL">Find My Moat</a> (as of September 2026)

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.